ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
ReNAgade Therapeutics a company unlocking the limitless potential for RNA medicines today announced the appointment of Laurie Stelzer as Chief Financial Officer. Ms. Stelzer most recently served as Chief Financial Officer of Mirati Therapeutics and brings over 25 years of experience to further strengthen ReNAgades leadership team.
Source: businesswireindia.com